San Francisco Chronicle - Monday, June 4, 2007
From nearly a standing start, he brought spending to $15 billion over five years. With that program nearly over, he wants to double the figure to $30 billion for the next five years, making Washington by far the biggest player in the global AIDS fight.
Critics say the money isn't enough, programs are burdened with conservative dogma on sex, and the sudden jump in dollars is an 11th hour bid to buff his image at next week's summit of economic powers.
All of that may carry an element of truth, but the White House's steady support deserves praise. The HIV virus that causes AIDS is mostly a poor-country disease, hitting sub-Sahara Africa hardest, even though it has far from gone away in this nation. It would be easy to dodge the AIDS challenge as distant, unwinnable or too costly.
The Bush proposal -- even at the $30 billion level -- won't defeat the disease. With no cure or vaccine at hand, the money is split between treatment drugs, which prolong life, and prevention programs such as condom distribution and education. AIDS remains a crushing numbers game: The first $15 billion in U.S. money brought life-extending drugs to just 2 million of the 40 million infected worldwide. The next stage envisions giving medicine to only 500,000 more.
Drugs are only one part of the battle. Future money will go to millions of African orphans, a subset of victims created when both parents die from AIDS. Prevention will also be expanded in hope of bringing down the rising curve of infections. For now, the "ABC" doctrine (abstinence, be faithful and use condoms) will stay as will requirements that grant recipients sign a pledge opposing prostitution, though AIDS treatment among this group is a must.
The Bush package could also tap the shame factor. It should oblige Congress and the next president to stick with the plan. It also forces the world's other wealthy nations to back up past pledges with money in the disease fight. It's a laudable legacy for this White House.
070604
SC070602
Copyright © 2007 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .